- 专利标题: Peripheral antegrade perfusion and occlusion device
-
申请号: US14907241申请日: 2015-06-24
-
公开(公告)号: US10328244B2公开(公告)日: 2019-06-25
- 发明人: Kenneth Eliasen , Adam J. Yestrepsky
- 申请人: EDWARDS LIFESCIENCES CORPORATION
- 申请人地址: US CA Irvine
- 专利权人: Edwards Lifesciences Corporation
- 当前专利权人: Edwards Lifesciences Corporation
- 当前专利权人地址: US CA Irvine
- 代理机构: Klarquist Sparkman, LLC
- 国际申请: PCT/US2015/037513 WO 20150624
- 国际公布: WO2015/200532 WO 20151230
- 主分类号: A61B17/12
- IPC分类号: A61B17/12 ; A61M25/10 ; A61M39/22
摘要:
This disclosure relates generally to systems and methods for occluding vessels of the heart and inducing cardioplegic arrest to facilitate the performance of cardiac procedures. An aortic occlusion and perfusion device includes an expandable member configured to expand within the aorta to secure the device within the aorta, and a catheter extending proximally from the expandable member and in fluid communication with the expandable member. The catheter can define a plurality of openings along its length through which blood can pass with one or more of the openings located proximal to the expandable member and one or more of the openings located within the expandable member. The device can also include a flow control sheath disposed around the catheter member such that axial movement of the flow control sheath relative to the catheter selectively occludes or uncovers one or more of the openings located proximal to the expandable member.
公开/授权文献
- US20160158506A1 PERIPHERAL ANTEGRADE PERFUSION AND OCCLUSION DEVICE 公开/授权日:2016-06-09
信息查询